Optiray 350 and Xanthoma - a phase IV clinical study of FDA data
We study 1,871 people who take Optiray 350 or have Xanthoma. No report of Xanthoma is found in people who take Optiray 350.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Optiray 350?
Optiray 350 has active ingredients of ioversol. eHealthMe is studying from 1,470 Optiray 350 users for its effectiveness, alternative drugs and more.
What is Xanthoma?
Xanthoma (deposition of yellowish cholesterol in skin) is found to be associated with 372 drugs and 281 conditions by eHealthMe.
Do you take Optiray 350 and have Xanthoma?Check whether Xanthoma is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Xanthoma and when was it recovered:
Expand to all the drugs that have ingredients of ioversol:
Alternative drugs to, pros and cons of Optiray 350:
- Optiray 350 (1,470 reports)
Xanthoma treatments and more:
- Xanthoma (401 reports)
COVID vaccines that are related to Xanthoma:
- Xanthoma in Moderna COVID Vaccine
- Xanthoma in Pfizer BioNTech Covid Vaccine
- Xanthoma in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Xanthoma:
All the conditions that are associated with Xanthoma:
How the study uses the data?
The study uses data from the FDA. It is based on ioversol (the active ingredients of Optiray 350) and Optiray 350 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zyrtec and Rickets - a second ago
- Swelling and Paranasal Sinus Hypersecretion - 19 seconds ago
- Multivitamin and Milnacipran Hydrochloride drug interaction - 20 seconds ago
- Dry Mouth in Bisoprolol Fumarate, how severe and when it was recovered? - 30 seconds ago
- Ramipril and Arthropathy - 32 seconds ago
- Pneumonia and Kawasaki'S Disease - 34 seconds ago
- Amnesteem and Clonazepam drug interaction - 42 seconds ago
- Rheumatoid Arthritis and Injection Site Hypersensitivity - 52 seconds ago
- Doryx and Taste Disturbance - 57 seconds ago
- Back Pain and Haematuria Aggravated - a minute ago